학술논문
Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study
Document Type
Article
Author
Source
In The Lancet Oncology February 2016 17(2):153-163
Subject
Language
ISSN
1470-2045